P
Paul A. Lotke
Researcher at University of Pennsylvania
Publications - 84
Citations - 6421
Paul A. Lotke is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Arthroplasty & Pulmonary embolism. The author has an hindex of 43, co-authored 84 publications receiving 6117 citations. Previous affiliations of Paul A. Lotke include Hospital of the University of Pennsylvania.
Papers
More filters
Journal ArticleDOI
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial
Alexander G.G. Turpie,Michael R. Lassen,Bruce L. Davidson,Kenneth A. Bauer,Michael Gent,Louis M. Kwong,Fred D. Cushner,Paul A. Lotke,Scott D. Berkowitz,Tiemo J. Bandel,Alice Benson,Frank Misselwitz,William D. Fisher +12 more
TL;DR: Oral rivaroxaban 10 mg once daily for 10-14 days was significantly superior to subcutaneous enoxaparin 30 mg given every 12 h for the prevention of venous thromboembolism after total knee arthroplasty.
Journal ArticleDOI
Total knee arthroplasty in morbidly obese patients.
TL;DR: It is concluded that total knee arthroplasty in morbidly obese patients can be successful but is associated with an increased rate of perioperative complications, including problems with wound-healing, infection, and avulsion of the medial collateral ligament.
Journal ArticleDOI
Stiffness after total knee arthroplasty. Prevalence of the complication and outcomes of revision.
TL;DR: Revision surgery was a satisfactory treatment option for stiffness, as the Knee Society scores improved, the flexion contractures diminished, and 93% of the knees had an increased arc of motion.
Journal ArticleDOI
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.
Charles W. Francis,Bruce L. Davidson,Scott D. Berkowitz,Paul A. Lotke,Jeffrey S. Ginsberg,Jay R. Lieberman,Anne K. Webster,James Whipple,Gary Peters,Clifford W. Colwell +9 more
TL;DR: This randomized, controlled trial compared ximelagatran with warfarin in 680 patients undergoing total knee arthroplasty and found that xIMelag atran was at least as effective as warfar in the prevention of venous thromboembolism.
Journal ArticleDOI
The results of spacer block technique in revision of infected total knee arthroplasty.
Robert E. Booth,Paul A. Lotke +1 more
TL;DR: An antibiotic-impregnated polymethylmethacrylate spacer block functions in the delayed exchange approach to chronic deep infection of total knee arthroplasty and provides antibiotic delivery, greater patient comfort and mobility, temporized reimplantation or other surgical options, and improved soft-tissue healing and tension.